ArrowMark Colorado Holdings LLC

Position in ERAS — Erasca, Inc.

CIK 1483859 Denver, CO

Position in ERAS

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$3,864,182

+$2,585,121 QoQ

Shares Held

210,927

+166.8% QoQ

Ownership

0.060%

of shares outstanding

% of Portfolio

0.16%

of 13F equity value

Holder Rank

#86

of 257 holders

Holding Since

Sep 2021

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ArrowMark Colorado Holdings LLC holds $294,624,620 across 32 Biotechnology names. ERAS ranks #22 (1.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABCL	AbCellera Biologics Inc.	4,105,095	$32,224,995
2	DFTX	Definium Therapeutics, Inc.	564,069	$26,533,805
3	MAZE	Maze Therapeutics, Inc.	767,383	$22,898,708
4	TNGX	Tango Therapeutics, Inc.	708,385	$22,144,115
5	RPRX	Royalty Pharma plc	366,199	$20,532,777
6	PRAX	Praxis Precision Medicines, Inc.	46,030	$15,410,383
7	ZBIO	Zenas BioPharma, Inc.	573,318	$14,550,810
8	CGON	CG Oncology, Inc.	155,354	$11,037,901

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,864,182	210,927	+166.8%	Shares	Sole	2026-08-13
2026-03-31	$1,279,061	79,052	-66.1%	Shares	Sole	2026-05-15
2023-09-30	$459,798	233,400	0.0%	Shares	Sole	2023-11-14
2023-06-30	$644,184	233,400	0.0%	Shares	Sole	2023-08-14
2023-03-31	$702,534	233,400	-79.7%	Shares	Sole	2023-05-15
2022-12-31	$4,966,046	1,152,215	+2.2%	Shares	Sole	2023-02-14
2022-09-30	$8,794,164	1,127,457	+82.1%	Shares	Sole	2022-11-14
2022-06-30	$3,448,927	619,197	+19.2%	Shares	Sole	2022-08-15
2022-03-31	$4,468,525	519,596	+5.4%	Shares	Sole	2022-05-16
2021-12-31	$7,677,761	492,796	+3.5%	Shares	Sole	2022-02-14
2021-09-30	$10,105,897	476,244	—	Shares	Sole	2021-11-15
No filing history on record for this holder in this stock.